We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Effectiveness of Facemasks Cast in Doubt

By HospiMedica International staff writers
Posted on 14 May 2018
A new study suggests that the majority of commercially available facemasks may not provide adequate protection against particulate matter (PM) air pollution.

Researchers at the Institute of Occupational Medicine (IOM; Edinburgh, United Kingdom), Durham University (United Kingdom; Durham), and other institutions conducted a study to evaluate the effectiveness of facemasks commercially available in China. More...
The nine masks selected claimed protection against a PM of 2.5, which includes soot, droplets, and other particles smaller than 2.5 microns in diameter. The masks’ filtration efficiency was tested by drawing airborne diesel exhaust through the material, and measuring PM2.5 and black carbon (BC) concentrations both upstream and downstream of the filtering medium.

Four masks were also selected for testing on volunteers, who were exposed to diesel exhaust inside an experimental chamber while doing sedentary and active tasks; BC concentrations were continuously monitored inside and outside the mask. The results revealed that penetration levels ranged from 0.26% to 29%, depending on flow rate and mask material. In the volunteer tests, average total inward leakage (TIL) of BC ranged from 3% to 68% in the sedentary tests, and from 7% to 66% in the active tests. Only one mask tested showed an average TIL of less than 10%, under both test conditions. The study was published on April 9, 2018, in BMJ Occupational and Environmental Medicine.

“Many commercially available face masks may not provide adequate protection, primarily due to poor facial fit. Our results indicate that further attention should be given to mask design and providing evidence-based guidance to consumers,” concluded lead author Professor John Cherrie, PhD, of the IOM, and colleagues. “If it's important for you to protect yourself or your family with masks, choose the best one you can and look for one marketed to workplaces. Don't opt for the cheapest option, choose the one that's most likely to do the best job.”

The annual average PM2.5 concentrations in Chinese megacities like Beijing exceed the World Health Organization guideline of 10 µg/m3, and corresponding BC concentrations are around 5 µg/m3. In fact, Beijing PM2.5 concentrations often reach unhealthy levels during the winter and near busy streets. Air pollution in China causes around 1.6 million premature deaths annually, and the loss of around 31 million disability-adjusted life years.

Related Links:
Institute of Occupational Medicine
Durham University


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.